Infection and chronic colonization of an intensive care unit patient's respiratory tract by a Klebsiella pneumoniae strain producing a novel AmpC β-lactamase different from that known

Clinical Infectious Diseases

Volumn 28, Issue 6, 1999, Pages 1338-1339

  Sahly, H ^a,b,c   Boehme, V ^a,b   Podschun, R ^a,b   Bauernfeind, A ^a,b   Folsch U R ^a,b   Ullmann, U ^a,b  

^a Dept of Med Microbiology Virology Department of Internal Medicine I Medical Clinic   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTIBUTEN; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; IMIPENEM; MEROPENEM; MONOBACTAM; QUINOLONE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CASE REPORT; HUMAN; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PLASMID; PRIORITY JOURNAL; RESPIRATORY SYSTEM;

EID: 0032979078     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517795     Document Type: Article

References (9)

1. 1. Jacoby GA, Medeiros AA. More extended spectrum β-lactamases. Antimicrob Agents Chemother 1991;35:1697-704.
2. 2. Jacoby G. Antimicrobial-resistant pathogens in the 1990s. Annu Rev Med 1996;47:169-79.
3. 3. Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990;34:2200-9.
4. 4. Bauernfeind A, Chong Y, Schweighart S. Extended spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycin. Infection 1989,17:316-21.
5. 5. Tzouvelekis LS, Tzelepi E, Mentis AF, Tsaknis A. Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. J Antimicrob Chemother 1996; 31:645-54.
6. 6. Jenks PJ, Hu YM, Danel F, Mehtar S, Livermore DM. Plasmid-mediated production of class I (AmpC) β-lactamase by two Klebsiella pneumoniae isolates from the UK. J Antimicrob Chemother 1995;35:235-6.
7. 7. Bauernfeind A, Jungwirth R, Schneider J, Sahly H, Ullmann U. Characteization of a novel AmpC-type β-lactamase, ACC-K, on Klebsiella pneumoniae [abstract no C2]. In: Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington DC: American Society for Microbiology, 1998:69.
8. 8. Di Martino P, Sirot D, Joly B, Rich C, Darfeuille-Michaud A. Relationship between adhesion to intestinal Caco-2 cells and multidrug resistance in Klebsiella pneumoniae clinical isolates. J Clin Microbiol 1997;35: 1499-503.
9. 9. Darfeuille-Michaud A, Jallat C, Aubel D, et al. R-Plasmid encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections. Infect Immun 1992;60:44-55.